Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

The Severe Typhoid Fever in Africa Program: Study Design and Methodology to Assess Disease Severity, Host Immunity, and Carriage Associated With Invasive Salmonellosis.

Park SE, Toy T, Cruz Espinoza LM, Panzner U, Mogeni OD, Im J, Poudyal N, Pak GD, Seo H, Chon Y, Schütt-Gerowitt H, Mogasale V, Ramani E, Dey A, Park JY, Kim JH, Seo HJ, Jeon HJ, Haselbeck A, Conway Roy K, MacWright W, Adu-Sarkodie Y, Owusu-Dabo E, Osei I, Owusu M, Rakotozandrindrainy R, Soura AB, Kabore LP, Teferi M, Okeke IN, Kehinde A, Popoola O, Jacobs J, Lunguya Metila O, Meyer CG, Crump JA, Elias S, Maclennan CA, Parry CM, Baker S, Mintz ED, Breiman RF, Clemens JD, Marks F.

Clin Infect Dis. 2019 Oct 30;69(Supplement_6):S422-S434. doi: 10.1093/cid/ciz715.

2.

Multicountry Distribution and Characterization of Extended-spectrum β-Lactamase-associated Gram-negative Bacteria From Bloodstream Infections in Sub-Saharan Africa.

Toy T, Pak GD, Duc TP, Campbell JI, El Tayeb MA, Von Kalckreuth V, Im J, Panzner U, Cruz Espinoza LM, Eibach D, Dekker DM, Park SE, Jeon HJ, Konings F, Mogeni OD, Cosmas L, Bjerregaard-Andersen M, Gasmelseed N, Hertz JT, Jaeger A, Krumkamp R, Ley B, Thriemer K, Kabore LP, Niang A, Raminosoa TM, Sampo E, Sarpong N, Soura A, Owusu-Dabo E, Teferi M, Yeshitela B, Poppert S, May J, Kim JH, Chon Y, Park JK, Aseffa A, Breiman RF, Schütt-Gerowitt H, Aaby P, Adu-Sarkodie Y, Crump JA, Rakotozandrindrainy R, Meyer CG, Sow AG, Clemens JD, Wierzba TF, Baker S, Marks F.

Clin Infect Dis. 2019 Oct 30;69(Supplement_6):S449-S458. doi: 10.1093/cid/ciz450.

3.

A Multicenter Cost-of-Illness and Long-term Socioeconomic Follow-up Study in the Severe Typhoid Fever in Africa Program: Study Protocol.

Ramani E, Park S, Toy T, Panzner U, Mogeni OD, Im J, Cruz Espinoza LM, Jeon HJ, Pak GD, Seo H, Chon Y, Rakotozandrindrainy R, Owusu-Dabo E, Osei I, Soura AB, Teferi M, Marks F, Mogasale V.

Clin Infect Dis. 2019 Oct 30;69(Supplement_6):S459-S465. doi: 10.1093/cid/ciz608.

4.

Assessment of Socio-Demographic Factors, Mother and Child Health Status, Water, Sanitation, and Hygienic Conditions Existing in a Hilly Rural Village of Nepal.

Bhandari P, Bak J, Lee KS, Chon Y, Bhattachan A, Rimal P, Shrestha BR, Bhandari B, Moon JO, Wu N, Chu WS, Song CK, Lee CS, Mogasale V, Ahn SH.

Int J Environ Res Public Health. 2019 Oct 17;16(20). pii: E3965. doi: 10.3390/ijerph16203965.

5.

Re-evaluating herd protection by Vi typhoid vaccine in a cluster randomized trial.

Ali M, Sur D, Kanungo S, Qadri F, Kim DR, Islam T, Im J, Ahmmed F, Chon Y, Khan AI, Zaman K, Marks F, Dutta S, Bhattacharya SK, Clemens JD.

Int Health. 2019 Oct 14. pii: ihz069. doi: 10.1093/inthealth/ihz069. [Epub ahead of print]

PMID:
31608962
6.

Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report.

Capeding MR, Alberto E, Sil A, Saluja T, Teshome S, Kim DR, Park JY, Yang JS, Chinaworapong S, Park J, Jo SK, Chon Y, Yang SY, Ham DS, Ryu JH, Lynch J, Kim JH, Kim H, Excler JL, Wartel TA, Sahastrabuddhe S.

Vaccine. 2019 Oct 1. pii: S0264-410X(19)31302-7. doi: 10.1016/j.vaccine.2019.09.074. [Epub ahead of print]

7.
8.

Validation of the Liver Disease Quality of Life Instrument 1.0 in Patients with Chronic Hepatitis B: A Prospective Study.

Ha Y, Hwang S, Chon YE, Kim MN, Lee JH, Hwang SG.

J Clin Med. 2019 May 10;8(5). pii: E656. doi: 10.3390/jcm8050656.

9.

Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

Chon YE, Park H, Hyun HK, Ha Y, Kim MN, Kim BK, Lee JH, Kim SU, Kim DY, Ahn SH, Hwang SG, Han KH, Rim KS, Park JY.

Cancers (Basel). 2019 Apr 10;11(4). pii: E509. doi: 10.3390/cancers11040509.

10.

Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial.

Ali M, Qadri F, Kim DR, Islam T, Im J, Ahmmed F, Chon Y, Islam Khan A, Zaman K, Marks F, Clemens JD.

Int J Epidemiol. 2019 Aug 1;48(4):1252-1261. doi: 10.1093/ije/dyz060.

11.

Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera.

Im J, Islam MT, Ahmmed F, Kim DR, Chon Y, Zaman K, Khan AI, Ali M, Marks F, Qadri F, Clemens JD.

PLoS Negl Trop Dis. 2019 Mar 14;13(3):e0007179. doi: 10.1371/journal.pntd.0007179. eCollection 2019 Mar.

12.

The HPAfrica protocol: Assessment of health behaviour and population-based socioeconomic, hygiene behavioural factors - a standardised repeated cross-sectional study in multiple cohorts in sub-Saharan Africa.

Pak GD, Haselbeck AH, Seo HW, Osei I, Amuasi J, Breiman RF, Cruz Espinosa LM, Holm M, Im J, Jang GH, Jeon HJ, Luby SP, Lunguya-Metila O, MacWright W, Mogeni OD, Okeke IN, Owusu-Dabo E, Park JK, Park SE, Popoola O, Seo HJ, Soura AB, Teferi M, Toy T, Chon Y, Rafindrakalia M, Rakotozandrindrainy R, Meyer CG, Marks F, Panzner U.

BMJ Open. 2018 Dec 19;8(12):e021438. doi: 10.1136/bmjopen-2017-021438.

13.

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B.

Lee YB, Ha Y, Chon YE, Kim MN, Lee JH, Park H, Kim KI, Kim SH, Rim KS, Hwang SG.

Clin Mol Hepatol. 2019 Mar;25(1):52-64. doi: 10.3350/cmh.2018.0040. Epub 2018 Oct 23.

14.

A randomized, observer-blinded, equivalence trial comparing two variations of Euvichol®, a bivalent killed whole-cell oral cholera vaccine, in healthy adults and children in the Philippines.

Russo P, Ligsay AD, Olveda R, Choi SK, Kim DR, Park JY, Park JY, Syed KA, Dey A, Kim YH, Lee SH, Kim J, Chon Y, Digilio L, Kim CW, Excler JL.

Vaccine. 2018 Jul 5;36(29):4317-4324. doi: 10.1016/j.vaccine.2018.05.102. Epub 2018 Jun 9.

15.

Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children.

Capeding MR, Teshome S, Saluja T, Syed KA, Kim DR, Park JY, Yang JS, Kim YH, Park J, Jo SK, Chon Y, Kothari S, Yang SY, Ham DS, Ryu JH, Hwang HS, Mun JH, Lynch JA, Kim JH, Kim H, Excler JL, Sahastrabuddhe S.

Vaccine. 2018 Jun 18;36(26):3794-3801. doi: 10.1016/j.vaccine.2018.05.038.

16.

Determining the Best Immunization Strategy for Protecting African Children Against Invasive Salmonella Disease.

Jeon HJ, Pak GD, Im J, Owusu-Dabo E, Adu-Sarkodie Y, Gassama Sow A, Bassiahi Soura A, Gasmelseed N, Keddy KH, Bjerregaard-Andersen M, Konings F, Aseffa A, Crump JA, Chon Y, Breiman RF, Park SE, Cruz Espinoza LM, Seo HJ, May J, Meyer CG, Andrews JR, Panzner U, von Kalckreuth V, Wierzba TF, Rakotozandrindrainy R, Dougan G, Levine MM, Hombach J, Kim JH, Clemens JD, Baker S, Marks F.

Clin Infect Dis. 2018 Nov 28;67(12):1824-1830. doi: 10.1093/cid/ciy386.

17.

Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance.

Chon YE, Jung KS, Kim MJ, Choi JY, An C, Park JY, Ahn SH, Kim BK, Kim SU, Park H, Hwang SK, Rim KS, Han KH, Kim DY.

Aliment Pharmacol Ther. 2018 Apr;47(8):1201-1212. doi: 10.1111/apt.14578. Epub 2018 Feb 28.

18.

The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter.

Lee HW, Kim KJ, Jung KS, Chon YE, Huh JH, Park KH, Chung JB, Kim CO, Han KH, Park JY.

PLoS One. 2017 Oct 27;12(10):e0187066. doi: 10.1371/journal.pone.0187066. eCollection 2017.

19.

Multiple Dural Arteriovenous Fistulas Presenting as Pulsatile Tinnitus Treated with External Manual Compression.

Oh SJ, Chon YI, Kong SK, Goh EK.

J Audiol Otol. 2017 Sep;21(3):156-159. doi: 10.7874/jao.2017.00115. Epub 2017 Sep 19.

20.

Corrigendum: Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.

Chon YE, Park JY, Myoung SM, Jung KS, Kim BK, Kim SU, Kim DY, Ahn SH, Han KH.

Am J Gastroenterol. 2017 Oct;112(10):1625. doi: 10.1038/ajg.2017.284. Epub 2017 Sep 12. No abstract available.

PMID:
28895581
21.

Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function.

Ha Y, Kim D, Han S, Chon YE, Lee YB, Kim MN, Lee JH, Park H, Rim KS, Hwang SG.

Cancer Res Treat. 2018 Jul;50(3):843-851. doi: 10.4143/crt.2017.232. Epub 2017 Sep 4.

22.

Reply to Huang et al.

Chon YE, Park JY.

Am J Gastroenterol. 2017 Sep;112(9):1478-1479. doi: 10.1038/ajg.2017.223. No abstract available.

PMID:
28874866
23.

Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.

Chon YE, Park JY, Myoung SM, Jung KS, Kim BK, Kim SU, Kim DY, Ahn SH, Han KH.

Am J Gastroenterol. 2017 Jun;112(6):882-891. doi: 10.1038/ajg.2017.93. Epub 2017 Apr 4. Erratum in: Am J Gastroenterol. 2017 Oct;112(10):1625.

PMID:
28374814
24.

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease.

Targan SR, Feagan B, Vermeire S, Panaccione R, Melmed GY, Landers C, Li D, Russell C, Newmark R, Zhang N, Chon Y, Hsu YH, Lin SL, Klekotka P.

Am J Gastroenterol. 2016 Nov;111(11):1599-1607. doi: 10.1038/ajg.2016.298. Epub 2016 Aug 2.

PMID:
27481309
25.

Erratum: Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response.

Lee HW, Chon YE, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Jung KS, Park YN, Han KH.

Gut Liver. 2016 Jul 15;10(4):653-655. doi: 10.5009/gnl150211. No abstract available.

26.

Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease.

Lee HW, Park SY, Kim SU, Jang JY, Park H, Kim JK, Lee CK, Chon YE, Han KH.

PLoS One. 2016 Jun 10;11(6):e0157358. doi: 10.1371/journal.pone.0157358. eCollection 2016.

27.

The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.

Chon YE, Kim KJ, Jung KS, Kim SU, Park JY, Kim do Y, Ahn SH, Chon CY, Chung JB, Park KH, Bae JC, Han KH.

Yonsei Med J. 2016 Jul;57(4):885-92. doi: 10.3349/ymj.2016.57.4.885.

28.

An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys): TRACES Study.

Chon YE, Kim DJ, Kim SG, Kim IH, Bae SH, Hwang SG, Heo J, Jang JW, Lee BS, Kim HJ, Jun DW, Kim KM, Chung WJ, Choi MS, Jang JY, Yim HJ, Tak WY, Yoon KT, Park JY, Han KH, Suk KT, Lee HW, Jang BK, Ahn SH.

Medicine (Baltimore). 2016 Apr;95(14):e3026. doi: 10.1097/MD.0000000000003026.

29.

Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.

Sun H, Dodick DW, Silberstein S, Goadsby PJ, Reuter U, Ashina M, Saper J, Cady R, Chon Y, Dietrich J, Lenz R.

Lancet Neurol. 2016 Apr;15(4):382-90. doi: 10.1016/S1474-4422(16)00019-3. Epub 2016 Feb 12.

PMID:
26879279
30.

Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients.

Jung KS, Park JY, Chon YE, Kim HS, Kang W, Kim BK, Kim SU, Kim do Y, Han KH, Ahn SH.

J Gastroenterol. 2016 Aug;51(8):830-9. doi: 10.1007/s00535-015-1153-1. Epub 2015 Dec 19.

PMID:
26687058
31.

Psychometric Properties of the Asthma Symptom Diary (ASD), a Diary for Use in Clinical Trials of Persistent Asthma.

Globe G, Wiklund I, Lin J, Chen WH, Martin M, Mattera MS, von Maltzahn R, Feng JY, Chon Y, Viswanathan HN, Schatz M.

J Allergy Clin Immunol Pract. 2016 Jan-Feb;4(1):60-6.e4. doi: 10.1016/j.jaip.2015.07.008. Epub 2015 Nov 6.

PMID:
26549745
32.

Noninvasive Prediction of Erosive Esophagitis Using a Controlled Attenuation Parameter (CAP)-Based Risk Estimation Model.

Chung H, Chon YE, Kim SU, Lee SK, Jung KS, Han KH, Chon CY.

Dig Dis Sci. 2016 Feb;61(2):507-16. doi: 10.1007/s10620-015-3902-7. Epub 2015 Oct 6.

PMID:
26441279
33.

Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response.

Lee HW, Chon YE, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Jung KS, Park YN, Han KH.

Gut Liver. 2016 May 23;10(3):429-36. doi: 10.5009/gnl15021. Erratum in: Gut Liver. 2016 Jul 15;10(4):653-5.

34.

Biomarker Profiles in Asthma With High vs Low Airway Reversibility and Poor Disease Control.

Busse WW, Holgate ST, Wenzel SW, Klekotka P, Chon Y, Feng J, Ingenito EP, Nirula A.

Chest. 2015 Dec;148(6):1489-1496. doi: 10.1378/chest.14-2457.

35.

Measuring the effect of asthma control on exacerbations and health resource use.

Sullivan PW, Campbell JD, Globe G, Ghushchyan VH, Bender B, Schatz M, Chon Y, Woolley JM, Magid DJ.

J Allergy Clin Immunol. 2015 Nov;136(5):1409-11.e1-6. doi: 10.1016/j.jaci.2015.04.046. Epub 2015 Jun 12. No abstract available.

PMID:
26073753
36.

A study to evaluate the safety, tolerability, and efficacy of brodalumab in subjects with rheumatoid arthritis and an inadequate response to methotrexate.

Pavelka K, Chon Y, Newmark R, Lin SL, Baumgartner S, Erondu N.

J Rheumatol. 2015 Jun;42(6):912-9. doi: 10.3899/jrheum.141271. Epub 2015 Apr 15.

PMID:
25877498
37.

Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy.

Chon YE, Jin B, Ahn SH, Kim S, Kim ND, Park JH, Nam CM, Kim KH, Hong SP, Choi SH, Kim DY, Park JY, Han KH.

Liver Int. 2015 Nov;35(11):2370-83. doi: 10.1111/liv.12845. Epub 2015 May 13.

PMID:
25872678
38.

Community-acquired vs. nosocomial spontaneous bacterial peritonitis in patients with liver cirrhosis.

Chon YE, Kim SU, Lee CK, Park JY, Kim DY, Han KH, Chon CY, Kim S, Jung KS, Ahn SH.

Hepatogastroenterology. 2014 Nov-Dec;61(136):2283-90.

PMID:
25741536
39.

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort.

Ahn SS, Chon YE, Kim BK, Kim SU, Kim DY, Ahn SH, Han KH, Park JY.

Clin Mol Hepatol. 2014 Sep;20(3):261-6. doi: 10.3350/cmh.2014.20.3.261. Epub 2014 Sep 25.

40.

Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea.

Chon YE, Jung KS, Kim KJ, Joo DJ, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim SU.

Dig Dis Sci. 2015 Jan;60(1):234-42. doi: 10.1007/s10620-014-3293-1. Epub 2014 Aug 14.

PMID:
25118979
41.

Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver disease.

Jung KS, Kim BK, Kim SU, Chon YE, Chun KH, Kim SB, Lee SH, Ahn SS, Park JY, Kim DY, Ahn SH, Park YN, Han KH.

PLoS One. 2014 Jun 5;9(6):e98689. doi: 10.1371/journal.pone.0098689. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e107331. Cheon, Kyung Hyun [corrected to Chun, Kyeong Hyeon].

42.

Dynamics of the liver stiffness value using transient elastography during the perioperative period in patients with valvular heart disease.

Chon YE, Kim SU, Park JY, Kim DY, Ahn SH, Han KH, Chon CY, Lee S.

PLoS One. 2014 Mar 26;9(3):e92795. doi: 10.1371/journal.pone.0092795. eCollection 2014.

43.

Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma.

Busse WW, Holgate S, Kerwin E, Chon Y, Feng J, Lin J, Lin SL.

Am J Respir Crit Care Med. 2013 Dec 1;188(11):1294-302. doi: 10.1164/rccm.201212-2318OC.

PMID:
24200404
44.

Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.

Chon YE, Jung KS, Kim SU, Park JY, Park YN, Kim DY, Ahn SH, Chon CY, Lee HW, Park Y, Han KH.

Liver Int. 2014 Jan;34(1):102-9. doi: 10.1111/liv.12282. Epub 2013 Sep 13.

PMID:
24028214
45.

Nicotine dependence syndrome scale and craving: comparing nicotine-dependent individuals with and without comorbid alcohol dependence.

Choi SW, Chon Y, Bhang SY, Jang YL, Won WY, Choi JT, Kim DJ.

Asia Pac Psychiatry. 2014 Jun;6(2):200-6. doi: 10.1111/appy.12008. Epub 2012 Nov 2.

PMID:
23857882
46.

Partial virological response to adefovir add-on lamivudine rescue therapy in patients with lamivudine-resistant chronic hepatitis B.

Chon YE, Park JY, Ahn SH, Kim DY, Han KH, Chon CY, Choi A, Kim SU.

Digestion. 2013;87(3):196-203. doi: 10.1159/000348853. Epub 2013 May 9.

PMID:
23689059
48.

Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients.

Busse WW, Wenzel SE, Meltzer EO, Kerwin EM, Liu MC, Zhang N, Chon Y, Budelsky AL, Lin J, Lin SL.

J Allergy Clin Immunol. 2013 Feb;131(2):339-45. doi: 10.1016/j.jaci.2012.10.013. Epub 2012 Nov 20.

PMID:
23174659
49.

Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis.

Chon YE, Choi EH, Song KJ, Park JY, Kim DY, Han KH, Chon CY, Ahn SH, Kim SU.

PLoS One. 2012;7(9):e44930. doi: 10.1371/journal.pone.0044930. Epub 2012 Sep 25.

50.

Transient elastography in real practice: a time for action?

Chon YE, Kim SU, Ahn SH.

J Gastroenterol Hepatol. 2012 Jul;27(7):1134-5. doi: 10.1111/j.1440-1746.2012.07175.x. No abstract available.

PMID:
22712705

Supplemental Content

Support Center